|
|
Volumn 6, Issue 3, 2007, Pages
|
|
Biosimilars: The impact of their heterogeneity on regulatory approval
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
RECOMBINANT PROTEIN;
BIOTECHNOLOGY;
CIRCULAR DICHROISM;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG QUALITY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG STABILITY;
EUROPEAN UNION;
FOOD AND DRUG ADMINISTRATION;
GENETIC ENGINEERING;
HUMAN;
HYDROPHILICITY;
HYDROPHOBICITY;
IMMUNOGENICITY;
LETTER;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
NONHUMAN;
PATENT;
PEPTIDE MAPPING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROTEIN AGGREGATION;
PROTEIN FOLDING;
PROTEIN MODIFICATION;
PROTEIN PROCESSING;
QUALITY CONTROL;
|
|
EID: 33847396966
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2283-c1 Document Type: Letter |
|
Times cited : (8)
|
|
References (6)
|
